LONDON, Nov. 23, 2017 (GLOBE NEWSWIRE) -- The report titled as “NGS Informatics Market- Global Opportunity Analysis And Industry Forecast (2017-2022)” states that the global next generation sequencing informatics market will grow at a CAGR of 22.1% during the forecast period to reach USD 1,305.1 million by 2022, according to Meticulous Research™. The NGS informatics market is driven by the reduced cost of DNA sequencing with the use of NGS informatics, various government initiatives, rising clinical applications, substitution of Microarray technology by NGS, continuous innovation & developments in technology, and increasing investments and funding for life sciences, pharmaceutical, and biotechnology research. Moreover, growing investments in the personalized medicine and increasing initiative from governments to promote use of NGS informatics is further propelling the growth of NGS informatics market globally. However, lack of accuracy & standardization of technology, ethical challenges, and reduced grants and funding from government in various countries are expected to inhibit the growth of NGS informatics market to some extent.

The global NGS informatics market is mainly segmented by product & services (NGS informatics services, data analysis and management tools, primary and secondary data analysis tools, and data interpretation & reporting tools), by function (biological interpretation, experimental design, sequencing, data management, and primary analysis), by application (biomarker discovery, precision medicine, diagnostics, drug discovery, and differential gene expression), and by end user (academics and research institutes, pharmaceuticals industry, biopharmaceuticals industry, government agencies, and hospitals & clinics).

Request Sample Report:

North America held the major share in the global NGS informatics market, followed by Asia-Pacific, and Europe. Increasing demand for clinical information technology, various government initiatives and availability of funds, and promotion of NGS by research laboratories and academicians are the major factors fueling the growth of NGS informatics market in North America. In addition, the presence of many bioinformatics players in this market improves the product accessibility which further propels the growth of the market.

The key players in the global NGS informatics market are Illumina, Inc. (U.S.), Thermo FisherScientific Inc.(U.S.), Qiagen N.V. (The Netherlands), Bina Technologies (U.S.), PerkinElmer Inc. (U.S.), BIOVIA (Dassault Systèmes) (U.S.), Amazon Web Services LLC(U.S.), International Business Machines Corporation (U.S.), GENEWIZ, Inc.(U.S.), Beijing Genomics Institute (BGI) (China), BioTeam Inc. (U.S.), Biomatters Ltd. (New Zealand), DNAnexus, Inc. (U.S.), DNASTAR, Inc. (U.S.), Eagle Genomics (U.K.), Edge Biosystems (U.S.), Genomatix AG (Germany), Partek Incorporated (U.S.), PierianDx, Inc. (U.S.), Real Time Genomics, Inc. (New Zealand), SoftGenetics, LLC (U.S.), and Sapio Sciences (U.S.).

Browse in-depth Report on

Contact Info-
Viren Shrivastava
AVP- Global Sales and Marketing
Meticulous Research™
Direct Lines: +1-646-781-8004 (North America)
+44-203-868-8738 (Europe)
+91 744-7780008 (Asia-Pacific)